• / Free eNewsletters & Magazine
  • / My Account
Home>Roche receives FDA clearance for next generation cobas MRSA/SA Test

Roche receives FDA clearance for next generation cobas MRSA/SA Test

3party Content

Mon, 26 Jan 2015

New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwidePLEASANTON, Calif., Jan. 26, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® MRSA/SA Test
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.